Inovalon to Present at 39th Annual J.P. Morgan Healthcare Conference
Inovalon (Nasdaq: INOV), a leader in cloud-based healthcare data solutions, will present at the 39th Annual J.P. Morgan Healthcare Conference virtually. The presentation is scheduled for 10:00 a.m. (EST) on January 12, 2021, featuring CEO Keith Dunleavy, M.D., and CFO Jonathan R. Boldt. Investors can access the live audio webcast through the Investor Relations section of Inovalon’s website. The company is known for its Inovalon ONE® Platform, which connects the healthcare ecosystem to improve care and financial performance.
- None.
- None.
BOWIE, Md., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Inovalon (Nasdaq: INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, today announced that Keith Dunleavy, M.D., chief executive officer and chairman of the board of Inovalon, and Jonathan R. Boldt, chief financial officer of Inovalon, will present at the 39th Annual J.P. Morgan Healthcare Conference, which will be held virtually.
The virtual presentation will take place at 10:00 a.m. (EST) on Tuesday, January 12, 2021. Investors may access a live audio webcast of the presentation on the Investor Relations section of Inovalon’s website at www.inovalon.com. An archived version will remain posted for a limited time.
About Inovalon
Inovalon is a leading provider of cloud-based platforms empowering data-driven healthcare. Through the Inovalon ONE® Platform, Inovalon brings to the marketplace a national-scale capability to interconnect with the healthcare ecosystem, aggregate and analyze data in real time, and empower the application of resulting insights to drive meaningful impact at the point of care. Leveraging its Platform, unparalleled proprietary datasets, and industry-leading subject matter expertise, Inovalon enables better care, efficiency, and financial performance across the healthcare ecosystem. From health plans and provider organizations, to pharmaceutical, medical device, and diagnostics companies, Inovalon’s unique achievement of value is delivered through the effective progression of “Turning Data into Insight, and Insight into Action®.” Supporting thousands of clients, including 24 of the top 25 U.S. health plans, 22 of the top 25 global pharma companies, 19 of the top 25 U.S. healthcare provider systems, and many of the leading pharmacy organizations, device manufacturers, and other healthcare industry constituents, Inovalon’s technology platforms and analytics are informed by data pertaining to more than 980,000 physicians, 565,000 clinical facilities, 324 million Americans, and 58 billion medical events. For more information, visit www.inovalon.com.
Contact:
Kim E. Collins
Senior Vice President, Corporate Communications
kcollins@inovalon.com
301-809-4000 x1473
Hulus Alpay
Vice President, Investor Relations
halpay@inovalon.com
301-809-4000 x1237
FAQ
When is Inovalon's presentation at the J.P. Morgan Healthcare Conference?
Who will present for Inovalon at the conference?
How can I access Inovalon's conference presentation?
What is the focus of Inovalon's cloud-based platform?
What is the stock symbol for Inovalon?
